JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Northrop, G.
Right arrow Articles by Parks, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Northrop, G.
Right arrow Articles by Parks, R. E., Jr.
Journal of Pharmacology And Experimental Therapeutics, Vol. 145, Issue 2, 135-141, 1964
Copyright © 1964 by American Society for Pharmacology and Experimental Therapeutics


STUDIES ON EPINEPHRINE AND 3’, 5’-AMP INDUCED HYPERGLYCEMIA EMPLOYING THE ISOLATED PERFUSED RAT LIVER PREPARATION

Gretajo Northrop 1 and R. E. Parks Jr. 1

1 Department of Pharmacology and Toxicology, The University of Wisconsin Medical School, Madison, Wisconsin

A method for perfusion of the rat liver has been described, with emphasis on the pharmacologic application. A photograph of the apparatus as well as a schematic representation is included. Contrary to previous publications from this and other laboratories, evidence has been presented that rat liver phosphorylase can be activated by exposure to epinephrine, demonstrating that rat liver phosphorylase is not maintained in the activated form at all times. Comparison of infusions of epinephrine and 3’, 5’-AMP showed that both of these agents cause hyperglycemia and phosphorylase activation, but differences were encountered in blood flow studies. Epinephrine caused a marked decrease in blood flow rate whereas the nucleotide did not affect the blood flow rate. Cyclic nucleotide infusions of 0.0002 mg/ml of blood did not elicit hyperglycemia, but at concentrations of 0.002 mg/ml and above definite hyperglycemia was observed. Specificity of the cyclic nucleotide was demonstrated by the absence of hyperglycemia following 5’-AMP infusions at a concentration of 2.4 mg/ml of blood.

Accepted on April 27, 1964







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1964 by the American Society for Pharmacology and Experimental Therapeutics.